Association of sustained virologic response with reduced progression to liver cirrhosis in elderly patients with chronic hepatitis C

References

• Mohd HanafiahKGroegerJFlaxmanADWiersmaSTGlobal epidemiology of hepatitis C virus infection: new estimates of age-specific antibody to HCV seroprevalenceHepatology2013571333134223172780
   PubMed Web of Science ®Google Scholar
• HajarizadehBGrebelyJDoreGJEpidemiology and natural history of HCV infectionNat Rev Gastroenterol Hepatol20131055356223817321
   PubMed Web of Science ®Google Scholar
• MaasoumyBWedemeyerHNatural history of acute and chronic hepatitis CBest Pract Res Clin Gastroenterol20122640141223199500
   PubMed Web of Science ®Google Scholar
• HuangCFChuangWLYuMLChronic hepatitis C infection in the elderlyKaohsiung J Med Sci20112753353722208535
   PubMed Web of Science ®Google Scholar
• TheinHHYiQDoreGJKrahnMDEstimation of stage-specific fibrosis progression rates in chronic hepatitis C virus infection: a meta-analysis and meta-regressionHepatology20084841843118563841
   PubMed Web of Science ®Google Scholar
• ThabutDLe CalvezSThibaultVHepatitis C in 6,865 patients 65 yr or older: a severe and neglected curable disease?Am J Gastroenterol20061011260126716771947
   PubMed Web of Science ®Google Scholar
• BrunoSBattezzatiPMBellatiGLong-term beneficial effects in sustained responders to interferon-alfa therapy for chronic hepatitis CJ Hepatol20013474875511434622
   PubMed Web of Science ®Google Scholar
• GeorgeSLBaconBRBruntEMClinical, virologic, histologic, and biochemical outcomes after successful HCV therapy: a 5-year follow-up of 150 patientsHepatology20094972973819072828
   PubMed Web of Science ®Google Scholar
• HuangJFYuMLLeeCMSustained virological response to interferon reduces cirrhosis in chronic hepatitis C: a 1,386-patient study from TaiwanAliment Pharmacol Ther2007251029103717439503
   PubMed Web of Science ®Google Scholar
• ShiratoriYImazekiFMoriyamaMHistologic improvement of fibrosis in patients with hepatitis C who have sustained response to interferon therapyAnn Intern Med200013251752410744587
   PubMed Web of Science ®Google Scholar
• NgVSaabSEffects of a sustained virologic response on outcomes of patients with chronic hepatitis CClin Gastroenterol Hepatol2011992393021699815
   PubMed Web of Science ®Google Scholar
• Trapero-MaruganMMendozaJChaparroMLong-term outcome of chronic hepatitis C patients with sustained virological response to peginterferon plus ribavirinWorld J Gastroenterol20111749349821274379
   PubMed Web of Science ®Google Scholar
• MorganRLBaackBSmithBDEradication of hepatitis C virus infection and the development of hepatocellular carcinoma: a meta-analysis of observational studiesAnn Intern Med201315832933723460056
   PubMed Web of Science ®Google Scholar
• FreiPLeuchtAKHeldUElderly age is not a negative predictive factor for virological response to therapy with pegylated interferon-alpha and ribavirin in chronic hepatitis C virus patientsLiver Int20143455155724034338
   PubMed Web of Science ®Google Scholar
• YangZZhuangLYangLEfficacy and safety of peginterferon plus ribavirin for patients aged ≥65 years with chronic hepatitis C: a systematic review and meta-analysisClin Res Hepatol Gastroenterol20143844045024176812
   PubMed Web of Science ®Google Scholar
• GonzalezHCJafriSMGordonSCRole of liver biopsy in the era of direct-acting antiviralsCurr Gastroenterol Rep20131530723319086
   PubMedGoogle Scholar
• LurieYWebbMCytter-KuintRShteingartSLederkremerGZNoninvasive diagnosis of liver fibrosis and cirrhosisWorld J Gastroenterol201521115671158326556987
   PubMed Web of Science ®Google Scholar
• European Association for the Study of the LiverEASL Clinical Practice Guidelines: management of hepatitis C virus infectionJ Hepatol20146039242024331294
   PubMed Web of Science ®Google Scholar
• FriedMWSide effects of therapy of hepatitis C and their managementHepatology200236S237S24412407599
   PubMed Web of Science ®Google Scholar
• OmataMKandaTYuMLAPASL consensus statements and management algorithms for hepatitis C virus infectionHepatol Int2012640943526201405
   PubMed Web of Science ®Google Scholar
• WongGLChanHLMakCWEntecavir treatment reduces hepatic events and deaths in chronic hepatitis B patients with liver cirrhosisHepatology2014581537154723389810
   PubMed Web of Science ®Google Scholar
• WaiCTGreensonJKFontanaRJA simple noninvasive index can predict both significant fibrosis and cirrhosis in patients with chronic hepatitis CHepatology20033851852612883497
   PubMed Web of Science ®Google Scholar
• RatgeDScheiblhuberBNitscheMKnabbeCHigh-speed detection of blood-borne hepatitis C virus RNA by single-tube real-time fluorescence reverse transcription-PCR with the LightCyclerClin Chem2000461987198911106331
   PubMed Web of Science ®Google Scholar
• BullockGCBrunsDEHaverstickDMHepatitis C genotype determination by melting curve analysis with a single set of fluorescence resonance energy transfer probesClin Chem2002482147215412446470
   PubMed Web of Science ®Google Scholar
• KanwalFKramerJRIlyasJDuanZEl-SeragHBHCV genotype 3 is associated with an increased risk of cirrhosis and hepatocellular cancer in a national sample of US Veterans with HCVHepatology2014609810524615981
   PubMed Web of Science ®Google Scholar
• AntonucciGLongoMAAngelettiCThe effect of age on response to therapy with peginterferon alpha plus ribavirin in a cohort of patients with chronic HCV hepatitis including subjects older than 65 yrAm J Gastroenterol20071021383139117403072
   PubMed Web of Science ®Google Scholar
• MindikogluALMillerRRHepatitis C in the elderly: epidemiology, natural history, and treatmentClin Gastroenterol Hepatol20097128134 quiz 12419084480
   PubMed Web of Science ®Google Scholar
• OzeTHiramatsuNYakushijinTIndications and limitations for aged patients with chronic hepatitis C in pegylated interferon alfa-2b plus ribavirin combination therapyJ Hepatol20115460461121145907
   PubMed Web of Science ®Google Scholar
• SeeffLBThe history of the “natural history” of hepatitis C (1968–2009)Liver Int200929899919207971
   PubMed Web of Science ®Google Scholar
• McCombsJMatsudaTTonnu-MiharaIThe risk of long-term morbidity and mortality in patients with chronic hepatitis C: results from an analysis of data from a Department of Veterans Affairs Clinical RegistryJAMA Intern Med201417420421224193887
   PubMed Web of Science ®Google Scholar
• FreemanAJDoreGJLawMGEstimating progression to cirrhosis in chronic hepatitis C virus infectionHepatology20013480981611584380
   PubMed Web of Science ®Google Scholar
• HondaTKatanoYShimizuJEfficacy of peginterferon-alpha-2b plus ribavirin in patients aged 65 years and older with chronic hepatitis CLiver Int20103052753719523048
   PubMed Web of Science ®Google Scholar
• HuangCFYangJFDaiCYEfficacy and safety of pegylated interferon combined with ribavirin for the treatment of older patients with chronic hepatitis CJ Infect Dis201020175175920102281
   PubMed Web of Science ®Google Scholar
• MonicaFLirussiFNassuatoGHepatitis C virus infection and related chronic liver disease in a resident elderly population: the Silea StudyJ Viral Hepat199853453519795919
   PubMed Web of Science ®Google Scholar
• NishikawaHIguchiEKoshikawaYThe effect of pegylated interferon-alpha2b and ribavirin combination therapy for chronic hepatitis C infection in elderly patientsBMC Res Notes2012513522405406
   PubMedGoogle Scholar
• TsengCWChenCYChangTTPeginterferon alfa-2a is associated with elevations in alanine aminotransferase at the end of treatment in chronic hepatitis C patients with sustained virologic responsePLoS One20149e10020724937007
   PubMed Web of Science ®Google Scholar
• PawlotskyJMNew hepatitis C therapies: the toolbox, strategies, and challengesGastroenterology20141461176119224631495
   PubMed Web of Science ®Google Scholar
• BerzigottiACasteraLUpdate on ultrasound imaging of liver fibrosisJ Hepatol20135918018223333447
   PubMed Web of Science ®Google Scholar